News Conference News TVT 2023 No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot Michael O'Riordan June 12, 2023
News Conference News TVT 2023 ‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients Michael O'Riordan June 09, 2023
News Conference News TVT 2023 Latest-Generation MitraClip Devices Make Strides Against Residual MR Shelley Wood June 09, 2023
News Conference News TVT 2023 Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years Michael O'Riordan June 09, 2023
News Conference News TVT 2022 Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests Michael O'Riordan June 09, 2022
News Conference News TVT 2021 Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market Todd Neale July 22, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021
News Conference News TVT 2020 Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO Shelley Wood June 24, 2020
News Conference News TVT 2020 MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT Michael O'Riordan June 21, 2020
News Conference News TVT 2019 Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results Shelley Wood June 19, 2019
News Conference News TVT 2019 What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches? Michael O'Riordan June 14, 2019